Literature DB >> 3082833

Intracellular uptake, retention and cytotoxic effect of adriamycin combined with hyperthermia in vitro.

S Nagaoka, S Kawasaki, K Sasaki, T Nakanishi.   

Abstract

The intracellular uptake, retention and cytotoxic effect of adriamycin (ADR) were investigated by a flow cytometry technique with NIH 3T3 cells. The intracellular uptake and cytotoxic effect of ADR increased as a function of exposure time and external drug concentration at 37 degrees. A good correlation was found between eventual survival and intracellular ADR uptake. The intracellular uptake and cytotoxic effect of ADR increased with increasing temperature and were shown to be functions of both incubation time and temperature. The intracellular uptake and cytotoxic effect of ADR were increased even at 39 degrees and 41 degrees, temperatures which had no effect on the viability of cells. The combination of hyperthermia (43 degrees) and ADR showed a synergistic effect. It was found that the cytotoxic effects of ADR in combination with various levels of hyperthermia were stronger than those which would be predicted from the intracellular ADR uptake at 37 degrees. The degree of enhancement was temperature-dependent. Since the efflux of intracellular ADR was the same with or without hyperthermia, the increased intracellular ADR uptake caused by elevated temperature was considered to result from an increase in influx.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082833

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  8 in total

1.  A mathematical model for comparison of bolus injection, continuous infusion, and liposomal delivery of doxorubicin to tumor cells.

Authors:  A W El-Kareh; T W Secomb
Journal:  Neoplasia       Date:  2000 Jul-Aug       Impact factor: 5.715

2.  Kinetic analysis of saturable myocardial uptake of idarubicin in rat heart: effect of doxorubicin and hypothermia.

Authors:  Wonku Kang; Michael Weiss
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

3.  Doxorubicin activity is enhanced by hyperthermia in a model of ex vivo vascular perfusion of human colon carcinoma.

Authors:  Pierluigi Pilati; Simone Mocellin; Carlo R Rossi; Romano Scalerta; Rita Alaggio; Luciano Giacomelli; Cristina Geroni; Donato Nitti; Mario Lise
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

4.  Laser flow cytometric studies on the intracellular accumulation of anthracyclines when combined with heat.

Authors:  Y Sakaguchi; Y Maehara; S Inutsuka; I Takahashi; M Yoshida; Y Emi; H Baba; K Sugimachi
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  The effect of hyperthermia in combination with melphalan on drug-sensitive and drug-resistant CHO cells in vitro.

Authors:  D A Bates; W J Mackillop
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

6.  Preoperative evaluation of the efficacy of radio-hyperthermo-chemotherapy for soft tissue sarcoma in a case series.

Authors:  Hisaki Aiba; Satoshi Yamada; Jun Mizutani; Norio Yamamoto; Hideki Okamoto; Katsuhiro Hayashi; Hiroaki Kimura; Akihiko Takeuchi; Shinji Miwa; Takashi Higuchi; Kensaku Abe; Yuta Taniguchi; Yoshihiro Araki; Hiroyuki Tsuchiya; Takanobu Otsuka
Journal:  PLoS One       Date:  2018-04-16       Impact factor: 3.240

7.  Investigation of Particle Accumulation, Chemosensitivity and Thermosensitivity for Effective Solid Tumor Therapy Using Thermosensitive Liposomes and Hyperthermia.

Authors:  Wouter J M Lokerse; Michiel Bolkestein; Timo L M Ten Hagen; Marion de Jong; Alexander M M Eggermont; Holger Grüll; Gerben A Koning
Journal:  Theranostics       Date:  2016-06-24       Impact factor: 11.556

8.  Clinical outcomes of radio-hyperthermo-chemotherapy for soft tissue sarcoma compared to a soft tissue sarcoma registry in Japan: a retrospective matched-pair cohort study.

Authors:  Hisaki Aiba; Satoshi Yamada; Jun Mizutani; Norio Yamamoto; Hideki Okamoto; Katsuhiro Hayashi; Hiroaki Kimura; Akihiko Takeuchi; Shinji Miwa; Akira Kawai; Kenichi Yoshimura; Hiroyuki Tsuchiya; Takanobu Otsuka
Journal:  Cancer Med       Date:  2018-02-26       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.